Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer

Overview of attention for article published in Frontiers in Pharmacology, December 2022

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,777 followers.

Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer https://t.co/0aINDgT5fh

New Research: Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer https://t.co/vYFT6MkdEZ #pharmacology

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.